Brawn Biotech Ltd has submitted an undertaking to BSE Limited regarding the non-applicability of related party transaction (RPT) filing requirements for the company.
The undertaking states that as of March 31, 2026, the company had a paid-up share capital of ₹3 crores and a net worth of approximately ₹4.32 crores. According to Regulation 15(2) of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015, the requirement for filing related party transactions is not applicable to companies whose paid-up equity share capital does not exceed ₹10 crore and net worth does not exceed ₹25 crore as on the last day of the previous financial year.
The company further confirms that both its paid-up share capital and net worth have remained below the specified thresholds of ₹10 crore and ₹25 crore respectively for the last three consecutive financial years.
Based on these criteria, Brawn Biotech is not required to comply with the related party transaction provisions under Regulation 23(9) for the quarter ended September 2026.
The undertaking was digitally signed by Priyanka Sharma, Company Secretary & Compliance Officer (Membership No. A50385) on November 5, 2026, at 16:21:43 IST.